|
SearchArthritis: Free Medical and Health Information on Arthritis Treatment and ResearchArthritis
Search within these results:
The current status on the use of biopharmaceuticals in the treatment of rheumatoid arthritis is reviewed.
Denmark Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patient
OBJECTIVE: Although heparanase is recognized as a proangiogenic factor, the involvement of heparanase in rheumatoid arthritis (RA) is unclear.
Canberra, Australia Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease that causes significant morbidity and mortality.
Kitakyusyu, 807-8555 Japan Safety of Biologic Therapy in Rheumatoid Arthritis and Other Autoimmune Diseases: Focus on Rituximab
OBJECTIVES: To review the safety of biologic agents used to treat rheumatoid arthritis (RA) and other autoimmune diseases, with a focus on rituximab.
Dallas, TX USA Longstanding rheumatoid arthritis (RA) leads to disability, caused mainly by joint destruction.
Zürich, Switzerland Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib
ABSTRACT: BACKGROUND: The efficacy, safety and tolerability of lumiracoxib, a novel selective cyclooxygenase-2 (COX-2) inhibitor, has been demonstrated in previous studies of patients with osteoarthritis (OA).
The Netherlands Psoriatic arthritis is an inflammatory arthropathy associated with the characteristic dermatologic lesions of psoriasis.
New York, NY USA Cartilage defects of the upper ankle joint reflect the problem that great force is transmitted and balanced out over a relatively small surface area.
Erlanger Allee 101
Jena, Germany 07740 Germany Clinical Outcome and Imaging Changes After Intraarticular (IA) Application of Etanercept or Methylpr
OBJECTIVE: To assess the magnetic resonance imaging (MRI) and ultrasound (US) changes in the wrist of patients with rheumatoid arthritis (RA) 4 weeks after an US guided intraarticular (IA) injection.
Genoa, Italy Italy This paper presents a retrospective series of 20 LPM semi-constrained ceramic coated cobalt chrome proximal interphalangeal joint arthroplasties performed consecutively in 12 patients for arthritis of the proximal interphalangeal joint by a single surgeon between 2000 and 2004.
Cheltenham, UK UK |
PartnersLinksApproved By
|